Top Markets
#1 Nesa Nesa +719.77%
#2 EXOD EXOD +22.78%
#3 Pons Pons +11.59%
#4 MetaDAO MetaDAO +11.24%
#5 Venom Venom +10.94%
#6 Ontology Gas Ontology Gas +9.15%
#7 Status Status +9.08%
#8 PondCoin PondCoin +8.53%
#9 Prom Prom +8.47%
#10 Wrapped NXM Wrapped NXM +7.71%
Coin of the day
Nesa Nesa
Instellingen
Taal
DUTCH
Valuta
USD
Thema
UnicoCell Biomed Co., Ltd. UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd.

6794
Rang in aandelen #19718
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Aandeelprijs
$2.40
Laatst gesynchroniseerd: 2026-08-25
Marktkapitalisatie
$152.78M
Verandering (1 dag)
0.67%
Verandering (1 jaar)
-4.09%
Land
TW
Handel UnicoCell Biomed Co., Ltd. (6794)

Categorie

Healthcare
Koersgeschiedenis voor UnicoCell Biomed Co., Ltd. (6794)
Hoogste slotkoers: $2.31 op 2026-08-01

Laagste slotkoers: $2.58 op 2024-05-01
Koersgeschiedenis van UnicoCell Biomed Co., Ltd. van 2024 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -2.18%
2025 20.54%
2024 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $123.02 -11.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH